Ion News and Research

RSS

Experimental antiarrhythmic drug dronedarone reduces death rate in patients with atrial fibrillation

Results from the ATHENA trial, reported in the 12th February issue of the New England Journal of Medicine , suggest that the (as yet unlicensed) antiarrhythmic drug dronedarone can reduce the incidence of cardiovascular-related hospitalisation or death in patients with atrial fibrillation.

16 Feb 2009

Boosting its infectivity turns benign virus into good gene therapy carrier for cystic fibrosis

Researchers from the University of California, Berkeley, and the University of Iowa have turned a relatively benign virus into a highly infectious form that is ideal as a carrier for gene therapy.

16 Feb 2009

Artificial cells, simple model for complex structure

A simple, chemical materials model may lead to a better understanding of the structure and organization of the cell according to a Penn State researcher.

16 Feb 2009

Cellular changes in the sleeping brain promote the formation of memories

If you ever argued with your mother when she told you to get some sleep after studying for an exam instead of pulling an all-nighter, you owe her an apology, because it turns out she's right.

15 Feb 2009

Quantum dot hazards

Quantum dots have the potential to bring many good things into the world: efficient solar power, targeted gene and drug delivery, solid-state lighting and advances in biomedical imaging among them.

2 Feb 2009

Century old drug clofazimine shows potential for multiple sclerosis

A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an antileprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases.

2 Feb 2009

Discovery of brain's memory 'buffer' in single cells

Individual nerve cells in the front part of the brain can hold traces of memories on their own for as long as a minute and possibly longer, researchers at UT Southwestern Medical Center have found.

27 Jan 2009

Slices of living human brain tissue are helping scientists identify new stroke therapies

Slices of living human brain tissue are helping scientists learn which drugs can block the waves of death that engulf and engorge brain cells following a stroke.

21 Jan 2009

New technique images whole cells in liquid with a scanning transmission electron microscope

Scientists have always wanted to take a closer look at biological systems and materials.

19 Jan 2009

Widespread antiviral drug use can accelerate the evolution of drug resistance in viruses

Influenza's ability to resist the effects of cheap and popular antiviral agents in Asia and Russia should serve as a cautionary tale about U.S. plans to use the antiviral Tamiflu in the event of widespread avian flu infection in humans, scientists say.

7 Jan 2009

Clioquinol - gastrointestinal drug could become anti-aging treatment

Recent animal studies have shown that clioquinol – an 80-year old drug once used to treat diarrhea and other gastrointestinal disorders – can reverse the progression of Alzheimer's, Parkinson's and Huntington's diseases.

6 Jan 2009

New understanding of ion channels in the body

A discovery by Canada-U.S. biophysicists will improve the understanding of ion channels, akin to little 'nano-machines' or 'nano-valves' in our body, which when they malfunction can cause genetic illnesses that attack muscles, the central nervous system and the heart.

18 Dec 2008

Key survival circuit discovered in Salmonella bacteria

Hundreds of trillions of bacteria make their home in the vertebrate gut. Though many of these microbes perform helpful duties for their host, others - the pathogens - are unwelcome visitors, causing disease.

17 Dec 2008

New cause of atrial fibrillation found

A new study shows that atrial fibrillation--the most common form of sustained heart arrhythmia--can be caused in an unexpected way.

12 Dec 2008

Vaxfectin-formulated H5N1 pandemic influenza achieves T-cell responses and cross-clade reactivity in humans

Vical Incorporated has announced that the company's Vaxfectin-formulated H5N1 pandemic influenza DNA vaccines induced T-cell responses against a matching strain of influenza virus and demonstrated cross-clade antibody responses against a different strain in a Phase 1 clinical trial.

11 Dec 2008

Ion News and Research

Experimental antiarrhythmic drug dronedarone reduces death rate in patients with atrial fibrillation

Boosting its infectivity turns benign virus into good gene therapy carrier for cystic fibrosis

Artificial cells, simple model for complex structure

Cellular changes in the sleeping brain promote the formation of memories

Quantum dot hazards

Century old drug clofazimine shows potential for multiple sclerosis

Discovery of brain's memory 'buffer' in single cells

Slices of living human brain tissue are helping scientists identify new stroke therapies

New technique images whole cells in liquid with a scanning transmission electron microscope

Widespread antiviral drug use can accelerate the evolution of drug resistance in viruses

Clioquinol - gastrointestinal drug could become anti-aging treatment

New understanding of ion channels in the body

Key survival circuit discovered in Salmonella bacteria

New cause of atrial fibrillation found

Vaxfectin-formulated H5N1 pandemic influenza achieves T-cell responses and cross-clade reactivity in humans

Hemichannels - new target to treat epileptic seizures following brain trauma or stroke

New set of controls for stem cells discovered

Breakthrough in strategy used to develop new pharmacological treatments for schizophrenia

Nitric oxide can change computational ability of the brain

Researchers discover how brain cells can survive a stroke

Enhancing confidence in chemical ionization spectrometry data eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News